HKD 0.62
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.61 Billion CNY | -24.44% |
2022 | 2.14 Billion CNY | -16.24% |
2021 | 2.55 Billion CNY | -19.93% |
2020 | 3.19 Billion CNY | 320.44% |
2019 | 759.78 Million CNY | 844.84% |
2018 | 80.41 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.46 Billion CNY | 0.0% |
2023 Q4 | 1.61 Billion CNY | 0.0% |
2023 FY | 1.61 Billion CNY | -24.44% |
2023 Q2 | 1.87 Billion CNY | 0.0% |
2022 FY | 2.14 Billion CNY | -16.24% |
2022 Q4 | 2.4 Billion CNY | 0.0% |
2022 Q2 | 2.84 Billion CNY | 0.0% |
2021 Q2 | 3.56 Billion CNY | 0.0% |
2021 FY | 2.55 Billion CNY | -19.93% |
2021 Q4 | 3.12 Billion CNY | 0.0% |
2020 Q2 | 708.75 Million CNY | 0.0% |
2020 FY | 3.19 Billion CNY | 320.44% |
2020 Q4 | 3.78 Billion CNY | 0.0% |
2019 Q2 | - HKD | 0.0% |
2019 Q4 | 849.88 Million CNY | 0.0% |
2019 FY | 759.78 Million CNY | 844.84% |
2018 FY | 80.41 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -294.785% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 85.609% |